Inventiva Bolsters Executive Team as It Nears Key Phase 3 Data Milestone

In preparation for a pivotal Phase 3 data readout for lanifibranor, Inventiva has expanded its leadership team with the appointment of three seasoned executives. Axel-Sven Malkomes, with extensive experience in investment banking and corporate leadership, joins as Chief Financial Officer. Susan Coles, an expert in legal and governance matters, assumes the role of Chief Legal Officer. Pamela Herbster, bringing vast experience in human resources, is named Chief People Officer.

This strategic enhancement positions Inventiva to handle potential commercialization challenges effectively. The appointments come ahead of the anticipated NATiV3 trial results for lanifibranor in treating MASH, expected later this year. Inventiva's CEO, Andrew Obenshain, expressed confidence in the new team's ability to lead the company through its next growth phase.